Publications
Search in 12961 publications:
12961 Publication(s)
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3.
Goetz M, Toi M, Huober J, Sohn J, Trédan O, Park I, Campone M, Chen S, Manso L, Paluch-Shimon S, Freedman O, O'Shaughnessy J, Pivot X, Tolaney S, Hurvitz S, Llombart-Cussac A, Andre V, Saha A, van Hal G, Shahir A, Iwata H, Johnston S. Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3. Ann Oncol 2024
May 8, 2024Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3.
May 8, 2024Ann Oncol 2024
Goetz Matthew P, Toi Masakazu, Huober Jens, Sohn Joo Hyuk, Trédan Olivier, Park In Hae, Campone Mario, Chen S-C, Manso L M, Paluch-Shimon Shani, Freedman Orit C, O'Shaughnessy Joyce, Pivot X, Tolaney Sara M, Hurvitz Sara A, Llombart-Cussac Antonio, Andre Valerie A M, Saha A, van Hal G, Shahir Ashwin, Iwata H, Johnston Stephen R D
Genetic variants for head size share genes and pathways with cancer.
Knol M, Poot R, Evans T, Satizabal C, Mishra A, Sargurupremraj M, van der Auwera S, Duperron M, Jian X, Hostettler I, van Dam-Nolen D, Lamballais S, Pawlak M, Lewis C, Carrion-Castillo A, van Erp T, Reinbold C, Shin J, Scholz M, Håberg A, Kämpe A, Li G, Avinun R, Atkins J, Hsu F, Amod A, Lam M, Tsuchida A, Teunissen M, Aygün N, Patel Y, Liang D, Beiser A, Beyer F, Bis J, Bos D, Bryan R, Bülow R, Caspers S, Catheline G, Cecil C, Dalvie S, Dartigues J, DeCarli C, Enlund-Cerullo M, Ford J, Franke B, Freedman B, Friedrich N, Green M, Haworth S, Helmer C, Hoffmann P, Homuth G, Ikram M, Jack C, Jahanshad N, Jockwitz C, Kamatani Y, Knodt A, Li S, Lim K, Longstreth W, Macciardi F, Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium, Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium, Mäkitie O, Mazoyer B, Medland S, Miyamoto S, Moebus S, Mosley T, Muetzel R, Mühleisen T, Nagata M, Nakahara S, Palmer N, Pausova Z, Preda A, Quidé Y, Reay W, Roshchupkin G, Schmidt R, Schreiner P, Setoh K, Shapland C, Sidney S, St Pourcain B, Stein J, Tabara Y, Teumer A, Uhlmann A, van der Lugt A, Vernooij M, Werring D, Windham B, Witte A, Wittfeld K, Yang Q, Yoshida K, Brunner H, Le Grand Q, Sim K, Stein D, Bowden D, Cairns M, Hariri A, Cheung C, Andersson S, Villringer A, Paus T, Cichon S, Calhoun V, Crivello F, Launer L, White T, Koudstaal P, Houlden H, Fornage M, Matsuda F, Grabe H, Debette S, Thompson P, Seshadri S, Adams H. Genetic variants for head size share genes and pathways with cancer. Cell Rep Med 2024:101529.
May 3, 2024Genetic variants for head size share genes and pathways with cancer.
May 3, 2024Cell Rep Med 2024:101529
Knol Maria J, Poot Raymond A, Evans Tavia E, Satizabal Claudia L, Mishra Aniket, Sargurupremraj Muralidharan, van der Auwera Sandra, Duperron Marie-Gabrielle, Jian Xueqiu, Hostettler Isabel, van Dam-Nolen Dianne H K, Lamballais Sander, Pawlak Mikolaj A, Lewis Cora E, Carrion-Castillo Amaia, van Erp Theo G M, Reinbold Céline S, Shin Jean, Scholz Markus, Håberg Asta K, Kämpe Anders, Li Gloria H Y, Avinun Reut, Atkins Joshua R, Hsu Fang-Chi, Amod AlyR, Lam Max, Tsuchida Ami, Teunissen Mariël W A, Aygün Nil, Patel Yash, Liang Dan, Beiser Alexa S, Beyer Frauke, Bis Joshua C, Bos Daniel, Bryan R Nick, Bülow Robin, Caspers Svenja, Catheline Gwenaëlle, Cecil Charlotte A M, Dalvie Shareefa, Dartigues Jean-François, DeCarli Charles, Enlund-Cerullo Maria, Ford Judith M, Franke Barbara, Freedman Barry I, Friedrich Nele, Green MeliJ, Haworth Simon, Helmer Catherine, Hoffmann Per, Homuth Georg, Ikram Mohammad Arfan, Jack Clifford R, Jahanshad Neda, Jockwitz Christiane, Kamatani Yoichiro, Knodt Annchen R, Li Shuo, Lim Keane, Longstreth W T, Macciardi Fabio, Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium, Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium, Mäkitie Outi, Mazoyer Bernard, Medland Sarah E, Miyamoto Susumu, Moebus Susanne, Mosley Thomas H, Muetzel Ryan, Mühleisen Thomas W, Nagata Manabu, Nakahara Soichiro, Palmer Nicholette D, Pausova Zdenka, Preda Adrian, Quidé Yann, Reay William R, Roshchupkin Gennady V, Schmidt Reinhold E, Schreiner Pamela J, Setoh Kazuya, Shapland Chin Yang, Sidney Stephen, St Pourcain Beate, Stein Jason L, Tabara Yasuharu, Teumer Alexander, Uhlmann Anne, van der Lugt Aad, Vernooij Meike W, Werring David J, Windham B Gwen, Witte A Veronica, Wittfeld Katharina, Yang Qiong, Yoshida Kazumichi, Brunner Han G, Le Grand Quentin, Sim Kang, Stein Dan J, Bowden Donald W, Cairns Murray J, Hariri Ahmad R, Cheung Ching-Lung, Andersson Sture, Villringer Arno, Paus Tomas, Cichon Sven, Calhoun Vince D, Crivello Fabrice, Launer Lenore J, White Tonya, Koudstaal Peter J, Houlden Henry, Fornage Myriam, Matsuda Fumihiko, Grabe Hans Jörgen, Debette Stephanie, Thompson Paul M, Seshadri Sudha, Adams Hieab H H
Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE.
Chen C, Shoamanesh A, Colorado P, Saad F, Lemmens R, De Marchis G, Caso V, Xu L, Heenan L, Masjuan J, Christensen H, Connolly S, Khatri P, Mundl H, Hart R, Smith E. Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE. Stroke 2024
May 1, 2024Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE.
May 1, 2024Stroke 2024
Chen Chih-Hao, Shoamanesh Ashkan, Colorado Pablo, Saad Feryal, Lemmens Robin, De Marchis Gian Marco, Caso Valeria, Xu Lizhen, Heenan Laura, Masjuan Jaime, Christensen Hanne, Connolly Stuart J, Khatri Pooja, Mundl Hardi, Hart Robert G, Smith Eric Edward
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study.
Goetz M, Cicin I, Testa L, Tolaney S, Huober J, Guarneri V, Johnston S, Martín M, Rastogi P, Harbeck N, Shahir A, Wei R, Andre V, Rugo H, O'Shaughnessy J. Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study. NPJ Breast Cancer 2024; 10:34.
Apr 26, 2024Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study.
Apr 26, 2024NPJ Breast Cancer 2024; 10:34
Goetz Matthew P, Cicin Irfan, Testa Laura, Tolaney Sara M, Huober Jens, Guarneri Valentina, Johnston Stephen R D, Martín Miguel, Rastogi Priya, Harbeck Nadia, Shahir Ashwin, Wei Ran, Andre Valerie A M, Rugo Hope S, O'Shaughnessy Joyce
Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE).
Meyer-Wilmes P, Huober J, Untch M, Blohmer J, Janni W, Denkert C, Klare P, Link T, Rhiem K, Bayer C, Reinisch M, Bjelic-Radisic V, Zahm D, Hanusch C, Solbach C, Heinrich G, Hartkopf A, Schneeweiss A, Fasching P, Filmann N, Nekljudova V, Holtschmidt J, Stickeler E, Loibl S. Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE). ESMO Open 2024; 9:103009.
Apr 24, 2024Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE).
Apr 24, 2024ESMO Open 2024; 9:103009
Meyer-Wilmes P, Huober Jens, Untch Michael, Blohmer J-U, Janni Wolfgang, Denkert Carsten, Klare Peter, Link Theresa, Rhiem Kerstin, Bayer C, Reinisch Mattea, Bjelic-Radisic Vesna, Zahm Dirk Michael, Hanusch Claus, Solbach Christine, Heinrich Georg, Hartkopf Andreas D, Schneeweiss Andreas, Fasching Peter Andreas, Filmann N, Nekljudova Valentina, Holtschmidt J, Stickeler Elmar, Loibl Sibylle
Bone morphogenic protein-4 availability in the cardiac microenviroment controls inflammation and fibrosis in autoimmune myocarditis
Pérez Shibayama C, Gil Cruz C, Cadosch N, Lütge M, Cheng H, De Martin A, Frischmann K, Joachimbauer A, Onder L, Papadopoulou I, Papadopoulou C, Ring S, Krebs P, P. Vu V, P. Nägele M, Rosi V, Parianos D, Zsilavecz V, Cooper L, Flammer A, Ruschitzka F, Reiner P, Schmidt D, Ludewig B. Bone morphogenic protein-4 availability in the cardiac microenviroment controls inflammation and fibrosis in autoimmune myocarditis. Nature Cardiovascular Research 2024; volume 3:301-316.
Apr 19, 2024Bone morphogenic protein-4 availability in the cardiac microenviroment controls inflammation and fibrosis in autoimmune myocarditis
Apr 19, 2024Nature Cardiovascular Research 2024; volume 3:301-316
Pérez Shibayama Christian Ivan, Gil Cruz Cristina, Cadosch Nadine, Lütge Mechthild, Cheng Hung-Wei, De Martin Angelina, Frischmann Kira, Joachimbauer Anna, Onder Lucas, Papadopoulou Iliana, Papadopoulou Chrysa, Ring Sandra, Krebs Philippe, P. Vu Vivian, P. Nägele Matthias, Rosi Valentina, Parianos Danae, Zsilavecz Valentin W, Cooper Leslie T., Flammer Andreas, Ruschitzka Frank, Reiner Peter P, Schmidt Dörthe, Ludewig Burkhard
The prevalence of imposter syndrome among neurosurgeons in Europe: An EANS YNC survey.
Zoia C, Stienen M, Zaed I, Menna G, Aldea C, Bartek J, Bauer M, Belo D, Drosos E, Freyschlag C, Kaprovoy S, Lepic M, Lippa L, Mohme M, Motov S, Schwake M, Spiriev T, Stengel F, Torregrossa F, Raffa G, Gandía-González M. The prevalence of imposter syndrome among neurosurgeons in Europe: An EANS YNC survey. Brain Spine 2024; 4:102816.
Apr 16, 2024The prevalence of imposter syndrome among neurosurgeons in Europe: An EANS YNC survey.
Apr 16, 2024Brain Spine 2024; 4:102816
Zoia Cesare, Stienen Martin N., Zaed Ismail, Menna Grazia, Aldea Cristina C, Bartek Jiri, Bauer Marlies, Belo Diogo, Drosos Evangelos, Freyschlag Christian F, Kaprovoy Stanislav, Lepic Milan, Lippa Laura, Mohme Malte, Motov Stefan, Schwake Michael, Spiriev Toma, Stengel Felix C, Torregrossa Fabio, Raffa Giovanni, Gandía-González Maria L
Experience with the utilization of new-generation shared-control robotic system for spinal instrumentation.
Haider G, Shah V, Lopez I, Wagner K, Stienen M, Veeravagu A. Experience with the utilization of new-generation shared-control robotic system for spinal instrumentation. J Neurosurg Sci 2024
Apr 12, 2024Experience with the utilization of new-generation shared-control robotic system for spinal instrumentation.
Apr 12, 2024J Neurosurg Sci 2024
Haider Ghani, Shah Vaibhavi, Lopez Ivan, Wagner Katherine E, Stienen Martin N., Veeravagu Anand
Free Flap Reconstruction of Sternal Defects after Cardiac Surgery: An Algorithmic Approach for Dealing with Sparse Recipient Vessels.
Bigdeli A, Falkner F, Schmidt V, Thomas B, Engel H, Reichenberger M, Germann G, Gazyakan E, Kneser U. Free Flap Reconstruction of Sternal Defects after Cardiac Surgery: An Algorithmic Approach for Dealing with Sparse Recipient Vessels. Plast Reconstr Surg Glob Open 2024; 12:e5722.
Apr 9, 2024Free Flap Reconstruction of Sternal Defects after Cardiac Surgery: An Algorithmic Approach for Dealing with Sparse Recipient Vessels.
Apr 9, 2024Plast Reconstr Surg Glob Open 2024; 12:e5722
Bigdeli Amir Khosrow, Falkner Florian, Schmidt Volker, Thomas Benjamin, Engel Holger, Reichenberger Matthias, Germann Günter, Gazyakan Emre, Kneser Ulrich
Baseline perihematomal edema, C-reactive protein, and 30-day mortality are not associated in intracerebral hemorrhage.
Sobowale O, Hostettler I, Wu T, Heal C, Wilson D, Shah D, Strbian D, Putaala J, Tatlisumak T, Vail A, Sharma G, Davis S, Werring D, Meretoja A, Allan S, Parry-Jones A. Baseline perihematomal edema, C-reactive protein, and 30-day mortality are not associated in intracerebral hemorrhage. Front Neurol 2024; 15:1359760.
Apr 5, 2024Baseline perihematomal edema, C-reactive protein, and 30-day mortality are not associated in intracerebral hemorrhage.
Apr 5, 2024Front Neurol 2024; 15:1359760
Sobowale Oluwaseun A, Hostettler Isabel, Wu Teddy Y, Heal Calvin, Wilson Duncan, Shah Darshan G, Strbian Daniel, Putaala Jukka, Tatlisumak Turgut, Vail Andy, Sharma Gagan, Davis Stephen M, Werring David J, Meretoja Atte, Allan Stuart M, Parry-Jones Adrian R
Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review.
Dittrich T, Vock D, Fisch U, Hert L, Baumann S, Kliem P, Rüegg S, Marsch S, De Marchis G, Sutter R. Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review. Neurocrit Care 2024
Apr 5, 2024Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review.
Apr 5, 2024Neurocrit Care 2024
Dittrich Tolga, Vock Dominik, Fisch Urs, Hert Lisa, Baumann Sira M, Kliem Paulina S C, Rüegg Stephan, Marsch Stephan C, De Marchis Gian Marco, Sutter Raoul
Accuracy between prehospital and hospital diagnosis in helicopter emergency medical services and its consequences for trauma care.
Müller-Nurasyid M, Hautz W, Louma Y, Knapp J, Schnüriger B, Simmen H, Pietsch U, Jakob D, Swiss Trauma Board. Accuracy between prehospital and hospital diagnosis in helicopter emergency medical services and its consequences for trauma care. Eur J Trauma Emerg Surg 2024
Apr 2, 2024Accuracy between prehospital and hospital diagnosis in helicopter emergency medical services and its consequences for trauma care.
Apr 2, 2024Eur J Trauma Emerg Surg 2024
Müller-Nurasyid Martina, Hautz Wolf E, Louma Yves, Knapp Jürgen, Schnüriger Beat, Simmen Hans-Peter, Pietsch Urs, Jakob Dominik A, Swiss Trauma Board
Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center.
Rudin S, Kriemler L, Dittrich T, Zietz A, Schweizer J, Arnold M, Peters N, Barinka F, Jung S, Arnold M, Fischer U, Rentsch K, Christ-Crain M, Katan M, De Marchis G. Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center. Swiss Med Wkly 2024; 154:3633.
Apr 2, 2024Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center.
Apr 2, 2024Swiss Med Wkly 2024; 154:3633
Rudin Salome, Kriemler Lilian, Dittrich Tolga, Zietz Annaelle, Schweizer Juliane, Arnold Markus, Peters Nils, Barinka Filip, Jung Simon, Arnold Marcel, Fischer Urs, Rentsch Katharina M, Christ-Crain Mirjam, Katan Mira, De Marchis Gian Marco
Baseline CD4 and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients.
Massa C, Karn T, Weber K, Schneeweiss A, Hanusch C, Blohmer J, Zahm D, Jackisch C, van Mackelenbergh M, Thomalla J, Marme F, Huober J, Müller V, Schem C, Mueller A, Stickeler E, Biehl K, Fasching P, Untch M, Loibl S, Denkert C, Seliger B. Baseline CD4 and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients. Clin Transl Med 2024; 14:e1617.
Apr 1, 2024Baseline CD4 and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients.
Apr 1, 2024Clin Transl Med 2024; 14:e1617
Massa Chiara, Karn Thomas, Weber Karsten E, Schneeweiss Andreas, Hanusch Claus, Blohmer Jens-Uwe, Zahm Dirk-Michael, Jackisch Christian, van Mackelenbergh Marion T, Thomalla Jörg, Marme Frederik, Huober Jens, Müller Volkmar, Schem Christian, Mueller Anja, Stickeler Elmar, Biehl Katharina, Fasching Peter Andreas, Untch Michael, Loibl Sibylle, Denkert Carsten, Seliger Barbara
Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials.
Fernandez-Martinez A, Rediti M, Tang G, Pascual T, Hoadley K, Venet D, Rashid N, Spears P, Islam N, El-Abed S, Bliss J, Lambertini M, Di Cosimo S, Huober J, Goerlitz D, Hu R, Lucas P, Swain S, Sotiriou C, Perou C, Carey L. Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials. JAMA Oncol 2024
Mar 28, 2024Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials.
Mar 28, 2024JAMA Oncol 2024
Fernandez-Martinez Aranzazu, Rediti Mattia, Tang Gong, Pascual Tomás, Hoadley Katherine A, Venet David, Rashid Naim U, Spears Patricia A, Islam N, El-Abed Sarra, Bliss Judith, Lambertini Matteo, Di Cosimo Serena, Huober Jens, Goerlitz David, Hu Rong, Lucas Peter C, Swain Sandra M, Sotiriou Christos, Perou Charles M, Carey Lisa A
Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial.
Beck-Schimmer B, Schadde E, Pietsch U, Filipovic M, Dübendorfer-Dalbert S, Fodor P, Hübner T, Schuepbach R, Steiger P, David S, Krüger B, Neff T, Schläpfer M. Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial. Ann Intensive Care 2024; 14:41.
Mar 27, 2024Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial.
Mar 27, 2024Ann Intensive Care 2024; 14:41
Beck-Schimmer Beatrice, Schadde Erik, Pietsch Urs, Filipovic Miodrag, Dübendorfer-Dalbert Seraina, Fodor Patricia, Hübner Tobias, Schuepbach Reto Andreas, Steiger Peter, David Sascha, Krüger Bernard D, Neff Thomas A, Schläpfer Martin
Absent leptomeningeal collateralization is associated with greatest benefit from mechanical thrombectomy in the 6-24 hour time window.
Dittrich T, von Streng T, Toebak A, Zietz A, Wagner B, Hänsel M, Sutter R, Katan M, Peters N, Michels L, Kulcsar Z, Karwacki G, Pileggi M, Cereda C, Wegener S, Bonati L, Psychogios M, De Marchis G. Absent leptomeningeal collateralization is associated with greatest benefit from mechanical thrombectomy in the 6-24 hour time window. Eur Stroke J 2024:23969873241239208.
Mar 18, 2024Absent leptomeningeal collateralization is associated with greatest benefit from mechanical thrombectomy in the 6-24 hour time window.
Mar 18, 2024Eur Stroke J 2024:23969873241239208
Dittrich Tolga, von Streng Tennessee, Toebak Anna, Zietz Annaelle, Wagner Benjamin, Hänsel Martin, Sutter Raoul, Katan Mira, Peters Nils, Michels Lars, Kulcsar Zsolt, Karwacki Grzegorz M, Pileggi Marco, Cereda Carlo Walter, Wegener Susanne, Bonati Leo H, Psychogios Marios-Nikos, De Marchis Gian Marco
Empfehlungen für die Diagnostik und Therapie der Behavioralen und Psychischen Symptome der Demenz (BPSD)
Savaskan E, Georgescu D, Becker S, Benkert B, Blessing A, Bürge M, Felbecker A, Hatzinger M, Hemmeter U, Klöppel S, Zúñiga F. Empfehlungen für die Diagnostik und Therapie der Behavioralen und Psychischen Symptome der Demenz (BPSD). Praxis 2024; 113:34-43.
Mar 11, 2024Empfehlungen für die Diagnostik und Therapie der Behavioralen und Psychischen Symptome der Demenz (BPSD)
Mar 11, 2024Praxis 2024; 113:34-43
Savaskan Egemen, Georgescu Dan, Becker Stefanie, Benkert Brigitte, Blessing Andreas, Bürge Markus, Felbecker Ansgar, Hatzinger Martin, Hemmeter Ulrich, Klöppel Stefan, Zúñiga Franziska
Cervical and thoracic spinal cord gray matter atrophy is associated with disability in patients with amyotrophic lateral sclerosis.
Wendebourg M, Weigel M, Weidensteiner C, Sander L, Kesenheimer E, Naumann N, Haas T, Madoerin P, Braun N, Neuwirth C, Weber M, Jahn K, Kappos L, Granziera C, Schweikert K, Sinnreich M, Bieri O, Schlaeger R. Cervical and thoracic spinal cord gray matter atrophy is associated with disability in patients with amyotrophic lateral sclerosis. Eur J Neurol 2024:e16268.
Mar 11, 2024Cervical and thoracic spinal cord gray matter atrophy is associated with disability in patients with amyotrophic lateral sclerosis.
Mar 11, 2024Eur J Neurol 2024:e16268
Wendebourg Maria Janina, Weigel Matthias, Weidensteiner Claudia, Sander Laura, Kesenheimer Eva, Naumann Nicole, Haas Tanja, Madoerin Philipp, Braun Nathalie, Neuwirth Christoph, Weber Markus, Jahn Kathleen, Kappos Ludwig, Granziera Cristina, Schweikert Kathi, Sinnreich Michael, Bieri Oliver, Schlaeger Regina
Endometriose – nur Schmerzen bei der Menstruation oder ein Risikofaktor für Krebs?
Markus A, Bischofberger S, Rduch T (2024). Endometriose – nur Schmerzen bei der Menstruation oder ein Risikofaktor für Krebs?. Presented at: Öffentlicher Vortrag, Kantonsspital St. Gallen
Mar 5, 2024Endometriose – nur Schmerzen bei der Menstruation oder ein Risikofaktor für Krebs?
Mar 5, 2024Öffentlicher Vortrag
Markus Alexander, Bischofberger S, Rduch Thomas